罗氏签署2亿美元协议，引进Freenome癌症筛查血液检测技术——Fierce Biotech报道
Roche inks $200M pact for Freenome's cancer screening blood test - Fierce Biotech
#Fierce Biotech#Freenome cancer#Roche inks#cancer screening#screening blood
生命科学资讯
生物技术与制药领域的最新动态
周五聚焦——口服SERDs瞄准早期机遇，Agios镰状细胞病药物受挫，Avadel不眠竞价战及其他——FirstWord Pharma
Friday Five — Oral SERDs eye earlier opportunities, Agios' SCD miss, Avadel's not-so-sleepy bidding war…and more - FirstWord Pharma
#Agios' SCD#SCD miss#Oral SERDs#bidding war#earlier opportunities
罗氏签署协议，获得Freenome癌症检测在美国以外地区的使用权 - MedTech Dive
Roche inks deal for rights to Freenome cancer tests outside US - MedTech Dive
#Freenome cancer#Roche inks#MedTech Dive#inks deal#cancer tests
Regeneron获两项Eylea批准，加剧与罗氏竞争 - 激烈医药市场动态
Regeneron wins 2 Eylea nods, ramping up competition with Roche - Fierce Pharma
#Eylea nods#Fierce Pharma#Regeneron wins#Roche Fierce#Pharma Regeneron
瑞银维持对罗氏控股(RHHVF)的买入评级 - 环球邮报
UBS Sticks to Its Buy Rating for Roche Holding AG (RHHVF) - The Globe and Mail
#Buy Rating#Roche Holding#UBS Sticks#Mail UBS#RHHVF
Freenome与罗氏联手开发癌症筛查检测 - MobiHealthNews
Freenome teams up with Roche for cancer screening tests - MobiHealthNews
#Freenome teams#cancer screening#screening tests#Roche#MobiHealthNews Freenome
奥莱玛制药：罗氏MBC数据推动股价翻倍——我主张谨慎行事（纳斯达克：OLMA）- 寻求阿尔法
Olema Pharmaceuticals: Shares Double On Roche's MBC Data - I Preach Caution (NASDAQ:OLMA) - Seeking Alpha
#Shares Double#MBC Data#Preach Caution#Seeking Alpha#Roche MBC
资深策略师解析：AI与信贷泡沫或已破裂，投资策略当如何调整——商业内幕
How one veteran strategist says to invest as bubbles in AI and credit may already be bursting - Business Insider
#Business Insider#veteran strategist#bursting Business#Business#Insider
C. Light公司项目入选罗氏多发性硬化创新挑战赛五大精选项目——雅虎财经报道
C. Light Named One of Five Selected Projects in the Roche MS Innovation Challenge - Yahoo Finance
#Light Named#Selected Projects#Innovation Challenge#Yahoo Finance#Challenge Yahoo
Sapphiros与罗氏达成战略合作，为罗氏提供10亿次侧流检测及未来分子即时检测服务 - 雅虎财经
Sapphiros announces a strategic agreement with Roche, providing Roche access to 1 billion lateral flow tests and access to future molecular point-of-care tests - Yahoo Finance
#providing Roche#Yahoo Finance#Roche access#billion lateral#future molecular
KaliVir Immunotherapeutics宣布与罗氏达成临床试验合作与供应协议，共同评估VET3-TGI联合阿特珠单抗（Tecentriq®）治疗晚期实体瘤的效果——雅虎财经报道
KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate VET3-TGI in Combination with Atezolizumab (Tecentriq®) in Advanced Solid Tumors - Yahoo Finance
#Immunotherapeutics Announces#Announces Clinical#Clinical Trial#Trial Collaboration#Supply Agreement
奥莱玛制药(OLMA)在罗氏乳腺癌试验成功后重新审视竞争优势 - 雅虎财经
Olema Pharmaceuticals (OLMA) Rethinks Competitive Edge After Roche’s Breast Cancer Trial Success - Yahoo Finance
#Rethinks Competitive#Competitive Edge#Breast Cancer#Cancer Trial#Olema Pharmaceuticals
罗氏：乳腺癌候选药物Giredestrant数据支持其潜在差异化地位——晨星加拿大
Roche: Data for Breast Cancer Drug Candidate Giredestrant Support Potential Differentiated Status - Morningstar Canada
#Breast Cancer#Cancer Drug#Drug Candidate#Candidate Giredestrant#Giredestrant Support
Freenome与罗氏合作，为非美国市场开发癌症筛查技术 - 医疗器械网络
Freenome and Roche partner on cancer screening technology for ex-US markets - Medical Device Network
#Medical Device#Device Network#Roche partner#cancer screening#screening technology
欧盟委员会批准罗氏Lunsumio皮下注射剂用于复发或难治性滤泡性淋巴瘤——雅虎财经
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma - Yahoo Finance
#Yahoo Finance#European Commission#Commission approves#approves Roche#Lunsumio subcutaneous
罗氏癌症研究获积极成果，其竞争对手股价飙升130%——投资者商业日报
Roche Had A Positive Cancer Study — And Its Rival Flew 130% - Investor's Business Daily
#Cancer Study#Rival Flew#Investor Business#Positive Cancer#Business Daily
罗氏药丸在早期乳腺癌治疗中取得进展——生物制药动态
Roche pill notches win in early breast cancer - BioPharma Dive
#Roche pill#BioPharma Dive#pill notches#notches win#early breast
罗氏口服SERD在乳腺癌关键试验中再获成功——FirstWord Pharma
Roche's oral SERD notches second pivotal breast cancer win - FirstWord Pharma
#oral SERD#SERD notches#Roche oral#FirstWord Pharma#pivotal breast
罗氏癌症药物试验结果积极，OLMA股价翻倍——Stocktwits报道
OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results - Stocktwits
#Stock Doubles#Roche Cancer#Cancer Drug#Drug Trial#Trial Yields
罗氏口服SERD药物二期临床试验再传捷报，三期辅助乳腺癌试验达标——Fierce Biotech报道
Roche's oral SERD goes 2 for 2, hitting goal in phase 3 adjuvant breast cancer trial - Fierce Biotech
#Fierce Biotech#oral SERD#hitting goal#adjuvant breast#Roche oral